Specifically, miR-29 plays a role in downregulating genes like CLDN1 and NKRF, which can lead to increased intestinal permeability, a phenomenon observed in studies on knockout mice and tissue samples from IBS patients. The gene discussed is NKRF; the disease is irritable bowel syndrome.